Academic Researchers Turn to Spotfire for Advanced Discovery Capabilities.

SOMERVILLE, Mass. -- Max Planck Institute of Biochemistry at Martinsried and German Cancer Research Center at Heidelberg to Enrich German Research Community with New Capabilities

Spotfire(R), Inc. (http://www.spotfire.com), a market leader in interactive, visual analytics for business decision-making, today announced significant momentum with academic research institutions. The Max Planck Institute of Biochemistry at Martinsried and the German Cancer Research Center (DKFZ) at Heidelberg, both leading research centers in Europe, are utilizing Spotfire DecisionSite(TM) to dramatically enhance their research capabilities. These institutions were showcased during Spotfire's European User Conference held in Koln, Germany, where researchers presented case studies.

Spotfire DecisionSite for Functional Genomics is an application that enables academic research groups to quickly and easily find and categorize important and complex genes and gene expression patterns. Its interactive, visual analysis environment incorporates high-impact visualization capabilities that let users examine the expression and annotation dimensions of their data and perform a wide array of numerical analyses.

"We take a very collaborative approach to research," commented Dr. Friedrich Lottspeich, the President of the German Society of Proteomics Research and head of Protein Analytics at the Max Planck Institute of Biochemistry at Martinsried. "Spotfire provides us the powerful analytic capability we need to advance our research combined with the ability to easily extend the research and discovery process across our entire staff, which is crucial for our success."

With DecisionSite for Functional Genomics, users have all the tools needed for collaboration and effective, interactive presentation of large amounts of complex gene function information. DecisionSite Guides are used to capture specific analysis workflows as step-by-step procedures for a variety of tasks within genomics research, so that even novice users can easily explore data using advanced analytic tools and dynamic, interactive visualizations. To extend the power of the application across the organization, these institutions will use DecisionSite Posters as the global publishing platform to share DecisionSite analysis results across research teams. Researchers can share analysis findings and distribute them through email, while also creating a searchable repository of research paths previously taken.

"The research breakthroughs these institutions have been able to achieve are remarkable. They are incredibly well-respected in genomic research," said Christopher Ahlberg, CEO, Spotfire. "We look forward to the news of even more discoveries through the application of Spotfire technology."

About Spotfire

Spotfire(R), Inc. provides interactive, visual data analytics applications and services that empower enterprises and their end-users to improve operational performance and gain an information advantage over the competition. Over 25,000 users in close to 1,000 organizations around the world use Spotfire DecisionSite to drive confident decision-making by quickly and easily spotting trends, outliers and unanticipated relationships in critical business data. The company maintains U.S. headquarters in Somerville, Mass., and European headquarters in Goteborg, Sweden. Additional information can be found at: http://www.spotfire.com.